Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0QUOUB
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
PLB-001
|
|||||
| Synonyms |
PLB-001
Click to Show/Hide
|
|||||
| Organization |
PrimeLink BioTherapeutics, suzhou, China.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Delta-like protein 3 (DLL3)
|
Antigen Info | ||||
| Payload Name |
Exatecan
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Conjugation via Phosphonamidate.
|
|||||